Related Experiment Video
Updated: Jun 16, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Pomegranate and breast cancer: possible mechanisms of prevention
Susan R Sturgeon1, Alayne G Ronnenberg
1Department of Public Health, School of Public Health and Health Sciences, University of Massachusetts-Amherst, Amherst, MA 01003, USA. ssturgeon@schoolph.umass.edu
Abstract:
Several mechanistic studies in cell culture and mouse models suggest possible estrogen receptor-mediated and non-estrogen receptor-mediated benefits of pomegranate juice with respect to breast cancer risk. These studies demonstrate that various constituents of pomegranates can inhibit aromatase and 17beta-hydroxysteroid dehydrogenase enzymes or have antiestrogenic activity. Additional large, well-controlled human studies are warranted to elucidate the effects of pomegranate juice intake on serum hormone levels. Clarifying the effects of pomegranate constituents on key hormones known to be involved in breast cancer could result in important information for consumers and shed further light on the impact of diet on breast cancer risk.
Insights
Pomegranate juice may reduce breast cancer risk by inhibiting key enzymes and exhibiting antiestrogenic activity. Further human studies are needed to confirm effects on hormone levels and diet
Area of Science:
- Oncology
- Endocrinology
- Nutritional Science
Background:
- Mechanistic studies suggest pomegranate juice (PJ) may influence breast cancer risk.
- Pomegranate constituents show potential estrogen receptor-mediated and non-estrogen receptor-mediated effects.
- In vitro and animal models indicate inhibition of key enzymes like aromatase by pomegranate compounds.
Purpose of the Study:
- To review the potential benefits of pomegranate juice in relation to breast cancer risk.
- To explore the mechanisms underlying the effects of pomegranate constituents on hormone levels.
- To identify the need for further human clinical trials.
Main Methods:
- Review of existing mechanistic studies in cell culture and mouse models.
- Analysis of research on pomegranate constituents' enzymatic and antiestrogenic activities.
- Identification of gaps in current human research regarding serum hormone level changes.
Main Results:
- Pomegranate constituents inhibit aromatase and 17beta-hydroxysteroid dehydrogenase enzymes.
- Evidence suggests antiestrogenic activity of compounds found in pomegranates.
- Current research is primarily based on preclinical models, lacking robust human data.
Conclusions:
- Pomegranate juice constituents possess properties that may lower breast cancer risk.
- Further large-scale, well-controlled human studies are essential.
- Understanding pomegranate's impact on hormone levels is crucial for consumer guidance and dietary recommendations in cancer prevention.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
